We are live on ! Find out more
Aristotle Capital Management

Aristotle Capital Management Portfolio holdings

AUM $47.8B
1-Year Est. Return 13.38%
This Fund
S&P 500
This Quarter Est. Return
+1.7%
1 Year Est. Return
+13.38%
3 Year Est. Return
+48.4%
5 Year Est. Return
+59.36%
10 Year Est. Return
+297.67%
AUM
$50B
AUM Growth
-$1.79B
Cap. Flow
-$2.34B
Cap. Flow %
-4.68%
Top 10 Hldgs %
30.22%
Holding
204
New
12
Increased
30
Reduced
122
Closed
12

Sector Composition

Rank Sector Weight
1 Financials 19.82%
2 Technology 16.63%
3 Materials 10.24%
4 Healthcare 8.75%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
51
Accenture
ACN
$104B
$131M 0.26%
488,906
-7,063
-1% -$1.79M
TT icon
52
Trane Technologies
TT
$104B
$130M 0.26%
333,555
MS icon
53
Morgan Stanley
MS
$341B
$118M 0.24%
663,487
-118,000
-15% -$19.7M
STZ icon
54
Constellation Brands
STZ
$22.4B
$115M 0.23%
836,218
-1,811,861
-68% -$249M
IR icon
55
Ingersoll Rand
IR
$34.7B
$98.7M 0.2%
1,245,490
-63,700
-5% -$5.03M
CVX icon
56
Chevron
CVX
$379B
$91.6M 0.18%
601,086
-34,309
-5% -$5.23M
HLN icon
57
Haleon
HLN
$43.1B
$79.1M 0.16%
7,825,273
-235,931
-3% -$2.24M
GSK icon
58
GSK
GSK
$103B
$76.6M 0.15%
1,561,143
-47,038
-3% -$2.19M
EFA icon
59
iShares MSCI EAFE ETF
EFA
$79.3B
$57.9M 0.12%
603,418
+181,112
+43% +$17.2M
RTO icon
60
Rentokil
RTO
$12.6B
$53.5M 0.11%
1,816,497
-83,479
-4% -$2.32M
AKZOY
61
DELISTED
Akzo Nobel NV
AKZOY
$52.5M 0.11%
2,263,549
-124,079
-5% -$2.88M
DEO icon
62
Diageo
DEO
$48.8B
$41.2M 0.08%
477,351
-72,520
-13% -$6.68M
FCFS icon
63
FirstCash
FCFS
$9.32B
$40.6M 0.08%
254,773
+4,137
+2% +$652K
IWD icon
64
iShares Russell 1000 Value ETF
IWD
$83.4B
$30.7M 0.06%
145,910
+111,750
+327% +$23.1M
SGOV icon
65
iShares 0-3 Month Treasury Bond ETF
SGOV
$100B
$27.8M 0.06%
277,083
-719,086
-72% -$72.3M
JAZZ icon
66
Jazz Pharmaceuticals
JAZZ
$16.4B
$27M 0.05%
158,837
+781
+0.5% +$120K
NCLH icon
67
Norwegian Cruise Line
NCLH
$9.22B
$16.4M 0.03%
733,618
+10,913
+2% +$230K
DLB icon
68
Dolby
DLB
$5.73B
$16M 0.03%
248,370
-4,316
-2% -$290K
ABBV icon
69
AbbVie
ABBV
$431B
$15.1M 0.03%
65,967
+43
+0.1% +$9.79K
CATH icon
70
Global X S&P 500 Catholic Values ETF
CATH
$1.34B
$10.8M 0.02%
131,269
+41,519
+46% +$3.4M
CTAS icon
71
Cintas
CTAS
$81.5B
$6.9M 0.01%
36,713
-1,125
-3% -$212K
ABT icon
72
Abbott
ABT
$182B
$6.8M 0.01%
54,257
EWY icon
73
iShares MSCI South Korea ETF
EWY
$24.8B
$6.22M 0.01%
63,965
-1,814
-3% -$166K
RY icon
74
Royal Bank of Canada
RY
$290B
$5.88M 0.01%
34,487
+1,017
+3% +$156K
MICC
75
The Magnum Ice Cream Company N.V.
MICC
$11.2B
$5.39M 0.01%
+338,018
New +$5.3M

Similar funds

Aristotle Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Aristotle Capital Management held 204 positions worth $50B, down 3.5% from $51.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Aristotle Capital Management withdrew a net $2.34B in Q4 2025, closing 12 positions and reducing 122 holdings. Its most notable exit was Unilever, an estimated $58.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Materials.

Against the trend, Aristotle Capital Management opened a new position in McCormick & Company Non-Voting worth $260M.

  • Aristotle Capital Management's largest Q4 2025 buy was McCormick & Company Non-Voting: 3,816,143 shares worth $260M.
  • Aristotle Capital Management added most to Wells Fargo in Q4 2025, an estimated $85.9M increase.
  • Aristotle Capital Management's biggest Q4 2025 reduction was Constellation Brands, cutting an estimated $249M.
  • Aristotle Capital Management fully exited Unilever in Q4 2025, selling an estimated $58.8M.
  • Aristotle Capital Management's ten largest holdings make up 30% of its $50B portfolio in Q4 2025.
  • Aristotle Capital Management opened 12 new positions and closed 12 in Q4 2025.
  • Aristotle Capital Management's portfolio value fell 3.5% quarter-over-quarter to $50B.

Based on Aristotle Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.